Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -0.93% 53.00 52.00 54.00 56.00 52.00 53.00 2,127,837 13:13:41
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 9.8 1.2 0.8 66.3 95

Omega Diagnostics Share Discussion Threads

Showing 16201 to 16222 of 19475 messages
Chat Pages: Latest  659  658  657  656  655  654  653  652  651  650  649  648  Older
DateSubjectAuthorDiscuss
30/10/2020
15:33
Just seen two buys 30k @ 84p what's that all about
teamwork1
30/10/2020
14:52
Well I see the market Muppets are up to tricks. Just a waiting game
brianp14
30/10/2020
14:46
approval could come any minute.
thehitman1
30/10/2020
14:19
Clearly a tree shake. Who is after our shares?
carlisle44
30/10/2020
14:11
Now 73.5p - bounced right off the support level
topnotch
30/10/2020
13:55
71p (mid-price) should be a fairly strong support level - lets she if she holds!!!
topnotch
30/10/2020
13:16
yeah should turn fairly soon.
thehitman1
30/10/2020
12:46
So not much more L&G stock to go and then it should be back over £1. Looks like the UK will follow France and Germany into another nationwide lockdown. ODX is firmly in line now to take orders on mass.
searcher0
30/10/2020
12:09
ODX COLLAPSING - END OF DREAMS FOR MUPPETS - That loser hitman was talking of £3 - more like 3p idiot :)
specialist is the living god
30/10/2020
12:01
COLLAPSING!!!
specialist is the living god
30/10/2020
12:01
ODX going straight to 10p - Bankruptcy beckons
specialist is the living god
30/10/2020
11:54
ODX - going straight to 35p - very sad!
specialist is the living god
30/10/2020
10:47
10.7k accumulator, £8k at a time... counted 12 so far
jusjusjus
30/10/2020
10:11
Terrific summary bomber13, many thanks from me too. Bring on the prospect of 2.5m tests per week....
rivaldo
30/10/2020
09:08
Low volume today, any sells lodged will take a time to move...
barrywhit
30/10/2020
08:56
Good post again bomber13...many thanks
barrywhit
30/10/2020
08:45
Bomber I echo Jurgen's post but still wonder what he was referring to when he mentioned the mystery person or organisation and didnt return to it.
ant15
30/10/2020
08:34
All in all , Wednesday's update and presentation were robust , honest and realistic in classic Colin King fashion in my view , and the points below are what I felt were new and reassuring news - 1) The possibility of an additional plant in Dundee has been discarded in favour of putting more capacity into the established Alva plant . Indeed , Omega published a chart for the first time showing lateral flow test capacity rising from 200/- tests per week in October to 600/- tests per week in January , and then onto 2m tests per week by end April . The CEO went on to say that 2 1/2 m tests per week were possible after that , and that Omega already had orders to fill November’s capacity of 300/- tests per week . Moreover , this capacity expansion is fully funded by the £11m of cash raised in the June placing at 40p per share . 2) Mologic’s ELISA test for COVID 19 has seen disappointing sales because Omega cannot match the scale of laboratory testing that the likes of Roche and Abbott can achieve . However , it is not dead in the water . The RTC is awaiting self-test approval for its gold standard lateral flow antibody test from the MHRA regulatory body any day now , and it is Omega’s understanding that there is no other competing antibody self-test awaiting approval . The main government contract for this test is with Abington Health Ltd , and Omega will supply a minimum of 25% of the consortium’s requirements . From end November , any orders received above this level from organisations/countries other than the UK , Omega will be allowed to fulfil under an additional profit-sharing mechanism . Omega’s strong belief is that the antibody self-test will come into its own once COVID vaccines are available . 3) Mologic’s lateral flow saliva antigen test represents a “ huge opportunity “ , and prototypes are being validated in Liverpool , Nottingham , Heathrow Airport and elsewhere with data being described as very encouraging . The development phase is expected to complete shortly allowing for technology transfer to Omega in November , CE Marking by December , and full commercialisation by Xmas or early January . This is the Christmas present that Omega’s CEO has alluded to before now . Lateral flow antigen saliva tests , because of their ease of use and speed of result , are likely to become the test of choice , and are strongly supported by the UK , the WHO , and all major countries . Indeed , for the first time Omega made specific mention of opportunities for all of its COVID 19 tests in the USA where they have appointed a new distributor . 4) Visitect CD4 for HIV sufferers is on track and gaining traction towards the 6m tests pa that are needed . This traction is coming from CHAI , PEPFAR , MSF , and , most recently , the UN agencies . Discussions with the latter are described as very encouraging for 2021 budgets . Omega’s selling price is US$4 per test at 70% gross margin , and the group is hopeful of lowering the roughly £1 per test cost of goods sold by half , which implies gross margins potentially rising to 85% . 5) October has witnessed a sharp recovery in Food Intolerance sales across the board from the previous 6 months of COVID effects , and the group has strong expectations that the market has bottomed . China remains a massive opportunity in self-test , and approval is expected any day . With priorities having been focussed on COVID remedies by the Chinese authorities , some delay in the approval process has inevitably occurred . Whilst there is arguably a lot of growth already priced into Omega's shareprice , there is also an awful lot of potential , and that potential is only now on the cusp of serious revenue growth without further recourse to shareholders .
bomber13
30/10/2020
08:32
C44 I wondered if its Bill Gates but also thought If I were NCYT I might be looking to take a meaningful chunk of the company as it would extend their offering to the market. There is clearly someone in the background as he alluded to before he "bit his lip" I suppose we will have to wait but at this share price and with the company's capacity to generate such large sale volumes. You have to wonder what he was referring to.
ant15
30/10/2020
07:49
https://www.thetimes.co.uk/article/coronavirus-saliva-tests-could-lift-capacity-to-1m-a-day-9hjvtgrvt?shareToken=51d61036898d4982468235162c03a888
ayl30
30/10/2020
01:22
andymunchkin19 Oct '20 - 08:07 - 12898 of 12941 Edit 0 2 1 OhMy lord itsCrashingDoon ———;——- justtrying128 Oct '20 - 13:06 - 12908 of 12941 0 1 0 50p soon ———;——̵2;—- Specialist is the living GOD28 Oct '20 - 13:58 - 12911 of 12941 0 0 0 25p soon. Fair value.
andymunchkin
29/10/2020
22:54
Exactly. I've seen maybe a dozen RNS's over the last couple of weeks showing L&G reducing stakes in companies - and none where they've increased. It's as likely to be something corporate as something company-specific. Although no-one could blame L&G for taking what must be huge profits!
rivaldo
Chat Pages: Latest  659  658  657  656  655  654  653  652  651  650  649  648  Older
ADVFN Advertorial
Your Recent History
LSE
ODX
Omega Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210121 03:32:21